Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q1 2023 Jazz Pharmaceuticals Earnings Conference Call. [Operator Instructions].
Source: insidermonkey.com
Stay updated with breaking news from Daniel Swisher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day, and thank you for standing by. Welcome to the Q1 2023 Jazz Pharmaceuticals Earnings Conference Call. [Operator Instructions].
Pfizer (PFE) CEO Albert Bourla, has come forward in support of the FDA after a Texas-based judge suspended the approval of abortion pill mifepristone. Read more here.
Pharma leaders support FDA amid mifepristone legal battle. From PR Week